Clifton, NJ, United States of America

Navnit Hargovindas Shah

USPTO Granted Patents = 74 

 

 

Average Co-Inventor Count = 4.5

ph-index = 13

Forward Citations = 852(Granted Patents)

Forward Citations (Not Self Cited) = 793(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Bridgewater, NJ (US) (2020 - 2021)
  • Clifton, NJ (US) (1982 - 2022)
  • Monmouth Junction, NJ (US) (2021 - 2024)

Company Filing History:


Years Active: 1982-2025

Loading Chart...
Loading Chart...
Loading Chart...
74 patents (USPTO):

Title: **Navnit Hargovindas Shah: A Pioneer in Pharmaceutical Innovations**

Introduction

Navnit Hargovindas Shah, based in Clifton, NJ, is an accomplished inventor with an impressive portfolio of 72 patents. His work primarily focuses on the development of innovative pharmaceutical compositions that enhance drug delivery and efficacy.

Latest Patents

Among his latest contributions to the field are two significant patents. The first patent is for "Sustained release compositions comprising liothyronine," which details floating gastroretentive compositions that work through a multilayer core. This core includes a pull layer with liothyronine combined with an acid and a gas-generating agent, and a push layer made from a swellable water-soluble hydrophilic polymer. The patented formulation ensures a sustained and controlled release of liothyronine, improving therapeutic outcomes.

The second patent focuses on "Extended release compositions comprising pyridostigmine." This invention pertains to extended release dosage forms designed to maintain stable plasma concentrations while minimizing burst releases. These dosage forms can take the shape of matrix tablets, gastroretentive tablets, and pellets, which are versatile enough for dosing in various pharmaceutical forms. The invention aims to enhance patient compliance by facilitating once-a-day administration of pyridostigmine bromide, delivering consistent drug release.

Career Highlights

Navnit Hargovindas Shah has made significant strides in the pharmaceutical industry through his affiliations with reputable organizations such as Hoffmann-La Roche Inc. and Kashiv Biosciences, LLC. His work at these companies has positioned him as a key figure in pharmaceutical research and development.

Collaborations

Throughout his career, Navnit has collaborated with fellow professionals in the industry, including Wantanee Phuapradit and Dipen Desai. These collaborations have driven many of his innovative contributions, fostering a culture of knowledge exchange and teamwork in developing new therapeutic solutions.

Conclusion

Navnit Hargovindas Shah stands out as an influential inventor in the realm of pharmaceutical innovations. His extensive patent portfolio and collaborations reflect his dedication to advancing drug delivery systems that not only improve patient care but also set new standards in the industry. Through his continued efforts, he remains a vital contributor to pharmaceutical science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…